NCT03679390

Brief Summary

The electroencephalography (EEG) is a noninvasive medical technique for monitoring and recording the electrical activity of brain. The Hilbert-Huang Transformation (HHT) was proposed to decompose EEG signal into intrinsic mode functions (IMF). HHT can obtain instantaneous frequency data and work well for nonstationary and nonlinear data. We applied this method in perioperative EEG signal analysis in order to find the energy shift and quantify the energy change during general anesthesia. Ketamine was a depolarized sedative which was wildly used in anesthesia. We are trying to find the energy change after ketamine injection, and the interaction between different oscillations in EEG. The whole brain mapping for ketamine and other sedatives interaction is the next step.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

September 19, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 20, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

July 6, 2021

Status Verified

June 1, 2020

Enrollment Period

3.5 years

First QC Date

September 19, 2018

Last Update Submit

July 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ketamine increase the dissociation energy in EEG

    ANOVA measurement

    one year

Study Arms (3)

10-20 y/o

EXPERIMENTAL

We will include the teenagers who need intravenous general anesthesia(IVGA), and inject propofol with/without ketamine 0.5mg/kg with full monitor. We will record the EEG during the who operation.

Drug: Ketamine

20-40y/o group

EXPERIMENTAL

We will include patients who need IVGA, and inject propofol with/without ketamine 0.5mg/kg with full monitor. We will record the EEG during the who operation.

Drug: Ketamine

>70 y/o

EXPERIMENTAL

We will include patients who need IVGA, and inject propofol with/without ketamine 0.5mg/kg with full monitor. We will record the EEG during the who operation.

Drug: Ketamine

Interventions

With the Ketamine group, we add ketamine 0.5mg/kg for anesthesia.

Also known as: control
10-20 y/o20-40y/o group>70 y/o

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiology I-II Not allergic to BIS probe Do not have wound or scar over forehead area

You may not qualify if:

  • patient refuse not suitable for propofol or ketamine injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Unconsciousness

Interventions

Ketamine

Condition Hierarchy (Ancestors)

Consciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Use same medication for different generations, focus on the reactions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2018

First Posted

September 20, 2018

Study Start

March 1, 2017

Primary Completion

September 1, 2020

Study Completion

September 1, 2020

Last Updated

July 6, 2021

Record last verified: 2020-06

Locations